Procedure
Hemoadsorption
Hemoadsorption is a medical procedure with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
60%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(1)
Other(1)
Detailed Status
Recruiting2
unknown1
Not yet recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
unknown120%
not_yet_recruiting120%
completed120%
recruiting240%
Recent Activity
2 active trials
Showing 5 of 5
recruiting
Hemodynamic, Laboratory, and Clinical Outcomes of Hemoadsorption Therapy
NCT07679555
recruitingnot_applicable
Hemoadsorption for Severe Ischemic Stroke
NCT07127484
not_yet_recruitingnot_applicable
Jafron Cytokine Adsorber During Pediatric Open-Heart Surgeries
NCT07393087
completed
CytoSorb in Patients With Liver Failure
NCT04511507
unknownnot_applicable
HaemoAdsorption Nach Reanimation An ECMO
NCT03632837
Clinical Trials (5)
Showing 5 of 5 trials
NCT07679555
Hemodynamic, Laboratory, and Clinical Outcomes of Hemoadsorption Therapy
NCT07127484Not Applicable
Hemoadsorption for Severe Ischemic Stroke
NCT07393087Not Applicable
Jafron Cytokine Adsorber During Pediatric Open-Heart Surgeries
NCT04511507
CytoSorb in Patients With Liver Failure
NCT03632837Not Applicable
HaemoAdsorption Nach Reanimation An ECMO
All 5 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 5